ANDA 91009, held by Actavis Labs Fl. Guaifenesin.
As of Nov 16, 2026, ANDA 91009 (Guaifenesin), held by Actavis Labs Fl, was first approved by FDA on Sep 3, 2015, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 3, 2015 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Guaifenesin1.2GM ยท tablet, extended release;oral | Guaifenesin | OTC |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters